[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Antiviral Drug Packaging Market Growth 2023-2029

May 2023 | 103 pages | ID: G0E7E4C2B405EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Antiviral Drug Packaging market size is projected to grow from US$ 25920 million in 2022 to US$ 33810 million in 2029; it is expected to grow at a CAGR of 3.9% from 2023 to 2029.

United States market for Antiviral Drug Packaging is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Antiviral Drug Packaging is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Antiviral Drug Packaging is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Antiviral Drug Packaging players cover Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF and Lonza, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Antiviral drug packaging is specially designed for packaging antiviral drugs. Antiviral drugs are a class of medication used specifically for treating viral infections such as influenza, herpes virus infections, viral hepatitis and human immunodeficiency virus.

LPI (LP Information)' newest research report, the “Antiviral Drug Packaging Industry Forecast” looks at past sales and reviews total world Antiviral Drug Packaging sales in 2022, providing a comprehensive analysis by region and market sector of projected Antiviral Drug Packaging sales for 2023 through 2029. With Antiviral Drug Packaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antiviral Drug Packaging industry.

This Insight Report provides a comprehensive analysis of the global Antiviral Drug Packaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antiviral Drug Packaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Antiviral Drug Packaging market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antiviral Drug Packaging and breaks down the forecast by material, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antiviral Drug Packaging.

This report presents a comprehensive overview, market shares, and growth opportunities of Antiviral Drug Packaging market by product material, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by material
  • Rigid Plastic
  • Flexible Blister Foils
  • Others
Segmentation by application
  • Pharmaceuticals
  • Healthcare
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Avery Dennison Corporation
  • E.I. du Pont de Nemours
  • CCL Industries Inc
  • BioCote
  • Avient
  • Mondi
  • Biomaster
  • BASF
  • Lonza
  • Takex Labo Co. Ltd
  • Berry
  • Lageen Tubes.
Key Questions Addressed in this Report

What is the 10-year outlook for the global Antiviral Drug Packaging market?

What factors are driving Antiviral Drug Packaging market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antiviral Drug Packaging market opportunities vary by end market size?

How does Antiviral Drug Packaging break out material, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antiviral Drug Packaging Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Antiviral Drug Packaging by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Antiviral Drug Packaging by Country/Region, 2018, 2022 & 2029
2.2 Antiviral Drug Packaging Segment by Material
  2.2.1 Rigid Plastic
  2.2.2 Flexible Blister Foils
  2.2.3 Others
2.3 Antiviral Drug Packaging Sales by Material
  2.3.1 Global Antiviral Drug Packaging Sales Market Share by Material (2018-2023)
  2.3.2 Global Antiviral Drug Packaging Revenue and Market Share by Material (2018-2023)
  2.3.3 Global Antiviral Drug Packaging Sale Price by Material (2018-2023)
2.4 Antiviral Drug Packaging Segment by Application
  2.4.1 Pharmaceuticals
  2.4.2 Healthcare
2.5 Antiviral Drug Packaging Sales by Application
  2.5.1 Global Antiviral Drug Packaging Sale Market Share by Application (2018-2023)
  2.5.2 Global Antiviral Drug Packaging Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Antiviral Drug Packaging Sale Price by Application (2018-2023)

3 GLOBAL ANTIVIRAL DRUG PACKAGING BY COMPANY

3.1 Global Antiviral Drug Packaging Breakdown Data by Company
  3.1.1 Global Antiviral Drug Packaging Annual Sales by Company (2018-2023)
  3.1.2 Global Antiviral Drug Packaging Sales Market Share by Company (2018-2023)
3.2 Global Antiviral Drug Packaging Annual Revenue by Company (2018-2023)
  3.2.1 Global Antiviral Drug Packaging Revenue by Company (2018-2023)
  3.2.2 Global Antiviral Drug Packaging Revenue Market Share by Company (2018-2023)
3.3 Global Antiviral Drug Packaging Sale Price by Company
3.4 Key Manufacturers Antiviral Drug Packaging Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Antiviral Drug Packaging Product Location Distribution
  3.4.2 Players Antiviral Drug Packaging Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR ANTIVIRAL DRUG PACKAGING BY GEOGRAPHIC REGION

4.1 World Historic Antiviral Drug Packaging Market Size by Geographic Region (2018-2023)
  4.1.1 Global Antiviral Drug Packaging Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Antiviral Drug Packaging Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Antiviral Drug Packaging Market Size by Country/Region (2018-2023)
  4.2.1 Global Antiviral Drug Packaging Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Antiviral Drug Packaging Annual Revenue by Country/Region (2018-2023)
4.3 Americas Antiviral Drug Packaging Sales Growth
4.4 APAC Antiviral Drug Packaging Sales Growth
4.5 Europe Antiviral Drug Packaging Sales Growth
4.6 Middle East & Africa Antiviral Drug Packaging Sales Growth

5 AMERICAS

5.1 Americas Antiviral Drug Packaging Sales by Country
  5.1.1 Americas Antiviral Drug Packaging Sales by Country (2018-2023)
  5.1.2 Americas Antiviral Drug Packaging Revenue by Country (2018-2023)
5.2 Americas Antiviral Drug Packaging Sales by Material
5.3 Americas Antiviral Drug Packaging Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antiviral Drug Packaging Sales by Region
  6.1.1 APAC Antiviral Drug Packaging Sales by Region (2018-2023)
  6.1.2 APAC Antiviral Drug Packaging Revenue by Region (2018-2023)
6.2 APAC Antiviral Drug Packaging Sales by Material
6.3 APAC Antiviral Drug Packaging Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Antiviral Drug Packaging by Country
  7.1.1 Europe Antiviral Drug Packaging Sales by Country (2018-2023)
  7.1.2 Europe Antiviral Drug Packaging Revenue by Country (2018-2023)
7.2 Europe Antiviral Drug Packaging Sales by Material
7.3 Europe Antiviral Drug Packaging Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antiviral Drug Packaging by Country
  8.1.1 Middle East & Africa Antiviral Drug Packaging Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Antiviral Drug Packaging Revenue by Country (2018-2023)
8.2 Middle East & Africa Antiviral Drug Packaging Sales by Material
8.3 Middle East & Africa Antiviral Drug Packaging Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antiviral Drug Packaging
10.3 Manufacturing Process Analysis of Antiviral Drug Packaging
10.4 Industry Chain Structure of Antiviral Drug Packaging

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Antiviral Drug Packaging Distributors
11.3 Antiviral Drug Packaging Customer

12 WORLD FORECAST REVIEW FOR ANTIVIRAL DRUG PACKAGING BY GEOGRAPHIC REGION

12.1 Global Antiviral Drug Packaging Market Size Forecast by Region
  12.1.1 Global Antiviral Drug Packaging Forecast by Region (2024-2029)
  12.1.2 Global Antiviral Drug Packaging Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antiviral Drug Packaging Forecast by Material
12.7 Global Antiviral Drug Packaging Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Avery Dennison Corporation
  13.1.1 Avery Dennison Corporation Company Information
  13.1.2 Avery Dennison Corporation Antiviral Drug Packaging Product Portfolios and Specifications
  13.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Avery Dennison Corporation Main Business Overview
  13.1.5 Avery Dennison Corporation Latest Developments
13.2 E.I. du Pont de Nemours
  13.2.1 E.I. du Pont de Nemours Company Information
  13.2.2 E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolios and Specifications
  13.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 E.I. du Pont de Nemours Main Business Overview
  13.2.5 E.I. du Pont de Nemours Latest Developments
13.3 CCL Industries Inc
  13.3.1 CCL Industries Inc Company Information
  13.3.2 CCL Industries Inc Antiviral Drug Packaging Product Portfolios and Specifications
  13.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 CCL Industries Inc Main Business Overview
  13.3.5 CCL Industries Inc Latest Developments
13.4 BioCote
  13.4.1 BioCote Company Information
  13.4.2 BioCote Antiviral Drug Packaging Product Portfolios and Specifications
  13.4.3 BioCote Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 BioCote Main Business Overview
  13.4.5 BioCote Latest Developments
13.5 Avient
  13.5.1 Avient Company Information
  13.5.2 Avient Antiviral Drug Packaging Product Portfolios and Specifications
  13.5.3 Avient Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Avient Main Business Overview
  13.5.5 Avient Latest Developments
13.6 Mondi
  13.6.1 Mondi Company Information
  13.6.2 Mondi Antiviral Drug Packaging Product Portfolios and Specifications
  13.6.3 Mondi Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Mondi Main Business Overview
  13.6.5 Mondi Latest Developments
13.7 Biomaster
  13.7.1 Biomaster Company Information
  13.7.2 Biomaster Antiviral Drug Packaging Product Portfolios and Specifications
  13.7.3 Biomaster Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Biomaster Main Business Overview
  13.7.5 Biomaster Latest Developments
13.8 BASF
  13.8.1 BASF Company Information
  13.8.2 BASF Antiviral Drug Packaging Product Portfolios and Specifications
  13.8.3 BASF Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 BASF Main Business Overview
  13.8.5 BASF Latest Developments
13.9 Lonza
  13.9.1 Lonza Company Information
  13.9.2 Lonza Antiviral Drug Packaging Product Portfolios and Specifications
  13.9.3 Lonza Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Lonza Main Business Overview
  13.9.5 Lonza Latest Developments
13.10 Takex Labo Co. Ltd
  13.10.1 Takex Labo Co. Ltd Company Information
  13.10.2 Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolios and Specifications
  13.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Takex Labo Co. Ltd Main Business Overview
  13.10.5 Takex Labo Co. Ltd Latest Developments
13.11 Berry
  13.11.1 Berry Company Information
  13.11.2 Berry Antiviral Drug Packaging Product Portfolios and Specifications
  13.11.3 Berry Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Berry Main Business Overview
  13.11.5 Berry Latest Developments
13.12 Lageen Tubes.
  13.12.1 Lageen Tubes. Company Information
  13.12.2 Lageen Tubes. Antiviral Drug Packaging Product Portfolios and Specifications
  13.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Lageen Tubes. Main Business Overview
  13.12.5 Lageen Tubes. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Antiviral Drug Packaging Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Antiviral Drug Packaging Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Rigid Plastic
Table 4. Major Players of Flexible Blister Foils
Table 5. Major Players of Others
Table 6. Global Antiviral Drug Packaging Sales by Material (2018-2023) & (K Units)
Table 7. Global Antiviral Drug Packaging Sales Market Share by Material (2018-2023)
Table 8. Global Antiviral Drug Packaging Revenue by Material (2018-2023) & ($ million)
Table 9. Global Antiviral Drug Packaging Revenue Market Share by Material (2018-2023)
Table 10. Global Antiviral Drug Packaging Sale Price by Material (2018-2023) & (US$/Unit)
Table 11. Global Antiviral Drug Packaging Sales by Application (2018-2023) & (K Units)
Table 12. Global Antiviral Drug Packaging Sales Market Share by Application (2018-2023)
Table 13. Global Antiviral Drug Packaging Revenue by Application (2018-2023)
Table 14. Global Antiviral Drug Packaging Revenue Market Share by Application (2018-2023)
Table 15. Global Antiviral Drug Packaging Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Antiviral Drug Packaging Sales by Company (2018-2023) & (K Units)
Table 17. Global Antiviral Drug Packaging Sales Market Share by Company (2018-2023)
Table 18. Global Antiviral Drug Packaging Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Antiviral Drug Packaging Revenue Market Share by Company (2018-2023)
Table 20. Global Antiviral Drug Packaging Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Antiviral Drug Packaging Producing Area Distribution and Sales Area
Table 22. Players Antiviral Drug Packaging Products Offered
Table 23. Antiviral Drug Packaging Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Antiviral Drug Packaging Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Antiviral Drug Packaging Sales Market Share Geographic Region (2018-2023)
Table 28. Global Antiviral Drug Packaging Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Antiviral Drug Packaging Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Antiviral Drug Packaging Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Antiviral Drug Packaging Sales Market Share by Country/Region (2018-2023)
Table 32. Global Antiviral Drug Packaging Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Antiviral Drug Packaging Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Antiviral Drug Packaging Sales by Country (2018-2023) & (K Units)
Table 35. Americas Antiviral Drug Packaging Sales Market Share by Country (2018-2023)
Table 36. Americas Antiviral Drug Packaging Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Antiviral Drug Packaging Revenue Market Share by Country (2018-2023)
Table 38. Americas Antiviral Drug Packaging Sales by Type (2018-2023) & (K Units)
Table 39. Americas Antiviral Drug Packaging Sales by Application (2018-2023) & (K Units)
Table 40. APAC Antiviral Drug Packaging Sales by Region (2018-2023) & (K Units)
Table 41. APAC Antiviral Drug Packaging Sales Market Share by Region (2018-2023)
Table 42. APAC Antiviral Drug Packaging Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Antiviral Drug Packaging Revenue Market Share by Region (2018-2023)
Table 44. APAC Antiviral Drug Packaging Sales by Material (2018-2023) & (K Units)
Table 45. APAC Antiviral Drug Packaging Sales by Application (2018-2023) & (K Units)
Table 46. Europe Antiviral Drug Packaging Sales by Country (2018-2023) & (K Units)
Table 47. Europe Antiviral Drug Packaging Sales Market Share by Country (2018-2023)
Table 48. Europe Antiviral Drug Packaging Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Antiviral Drug Packaging Revenue Market Share by Country (2018-2023)
Table 50. Europe Antiviral Drug Packaging Sales by Type (2018-2023) & (K Units)
Table 51. Europe Antiviral Drug Packaging Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Antiviral Drug Packaging Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Antiviral Drug Packaging Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Antiviral Drug Packaging Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Antiviral Drug Packaging Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Antiviral Drug Packaging Sales by Material (2018-2023) & (K Units)
Table 57. Middle East & Africa Antiviral Drug Packaging Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Antiviral Drug Packaging
Table 59. Key Market Challenges & Risks of Antiviral Drug Packaging
Table 60. Key Industry Trends of Antiviral Drug Packaging
Table 61. Antiviral Drug Packaging Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Antiviral Drug Packaging Distributors List
Table 64. Antiviral Drug Packaging Customer List
Table 65. Global Antiviral Drug Packaging Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Antiviral Drug Packaging Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Antiviral Drug Packaging Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Antiviral Drug Packaging Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Antiviral Drug Packaging Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Antiviral Drug Packaging Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Antiviral Drug Packaging Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Antiviral Drug Packaging Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Antiviral Drug Packaging Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Antiviral Drug Packaging Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Antiviral Drug Packaging Sales Forecast by Material (2024-2029) & (K Units)
Table 76. Global Antiviral Drug Packaging Revenue Forecast by Material (2024-2029) & ($ Millions)
Table 77. Global Antiviral Drug Packaging Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Antiviral Drug Packaging Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Avery Dennison Corporation Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 80. Avery Dennison Corporation Antiviral Drug Packaging Product Portfolios and Specifications
Table 81. Avery Dennison Corporation Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Avery Dennison Corporation Main Business
Table 83. Avery Dennison Corporation Latest Developments
Table 84. E.I. du Pont de Nemours Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 85. E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolios and Specifications
Table 86. E.I. du Pont de Nemours Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. E.I. du Pont de Nemours Main Business
Table 88. E.I. du Pont de Nemours Latest Developments
Table 89. CCL Industries Inc Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 90. CCL Industries Inc Antiviral Drug Packaging Product Portfolios and Specifications
Table 91. CCL Industries Inc Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. CCL Industries Inc Main Business
Table 93. CCL Industries Inc Latest Developments
Table 94. BioCote Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 95. BioCote Antiviral Drug Packaging Product Portfolios and Specifications
Table 96. BioCote Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. BioCote Main Business
Table 98. BioCote Latest Developments
Table 99. Avient Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 100. Avient Antiviral Drug Packaging Product Portfolios and Specifications
Table 101. Avient Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Avient Main Business
Table 103. Avient Latest Developments
Table 104. Mondi Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 105. Mondi Antiviral Drug Packaging Product Portfolios and Specifications
Table 106. Mondi Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Mondi Main Business
Table 108. Mondi Latest Developments
Table 109. Biomaster Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 110. Biomaster Antiviral Drug Packaging Product Portfolios and Specifications
Table 111. Biomaster Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Biomaster Main Business
Table 113. Biomaster Latest Developments
Table 114. BASF Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 115. BASF Antiviral Drug Packaging Product Portfolios and Specifications
Table 116. BASF Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. BASF Main Business
Table 118. BASF Latest Developments
Table 119. Lonza Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 120. Lonza Antiviral Drug Packaging Product Portfolios and Specifications
Table 121. Lonza Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Lonza Main Business
Table 123. Lonza Latest Developments
Table 124. Takex Labo Co. Ltd Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 125. Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolios and Specifications
Table 126. Takex Labo Co. Ltd Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Takex Labo Co. Ltd Main Business
Table 128. Takex Labo Co. Ltd Latest Developments
Table 129. Berry Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 130. Berry Antiviral Drug Packaging Product Portfolios and Specifications
Table 131. Berry Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Berry Main Business
Table 133. Berry Latest Developments
Table 134. Lageen Tubes. Basic Information, Antiviral Drug Packaging Manufacturing Base, Sales Area and Its Competitors
Table 135. Lageen Tubes. Antiviral Drug Packaging Product Portfolios and Specifications
Table 136. Lageen Tubes. Antiviral Drug Packaging Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Lageen Tubes. Main Business
Table 138. Lageen Tubes. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Antiviral Drug Packaging
Figure 2. Antiviral Drug Packaging Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antiviral Drug Packaging Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Antiviral Drug Packaging Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Antiviral Drug Packaging Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Rigid Plastic
Figure 10. Product Picture of Flexible Blister Foils
Figure 11. Product Picture of Others
Figure 12. Global Antiviral Drug Packaging Sales Market Share by Material in 2022
Figure 13. Global Antiviral Drug Packaging Revenue Market Share by Material (2018-2023)
Figure 14. Antiviral Drug Packaging Consumed in Pharmaceuticals
Figure 15. Global Antiviral Drug Packaging Market: Pharmaceuticals (2018-2023) & (K Units)
Figure 16. Antiviral Drug Packaging Consumed in Healthcare
Figure 17. Global Antiviral Drug Packaging Market: Healthcare (2018-2023) & (K Units)
Figure 18. Global Antiviral Drug Packaging Sales Market Share by Application (2022)
Figure 19. Global Antiviral Drug Packaging Revenue Market Share by Application in 2022
Figure 20. Antiviral Drug Packaging Sales Market by Company in 2022 (K Units)
Figure 21. Global Antiviral Drug Packaging Sales Market Share by Company in 2022
Figure 22. Antiviral Drug Packaging Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Antiviral Drug Packaging Revenue Market Share by Company in 2022
Figure 24. Global Antiviral Drug Packaging Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Antiviral Drug Packaging Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Antiviral Drug Packaging Sales 2018-2023 (K Units)
Figure 27. Americas Antiviral Drug Packaging Revenue 2018-2023 ($ Millions)
Figure 28. APAC Antiviral Drug Packaging Sales 2018-2023 (K Units)
Figure 29. APAC Antiviral Drug Packaging Revenue 2018-2023 ($ Millions)
Figure 30. Europe Antiviral Drug Packaging Sales 2018-2023 (K Units)
Figure 31. Europe Antiviral Drug Packaging Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Antiviral Drug Packaging Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Antiviral Drug Packaging Revenue 2018-2023 ($ Millions)
Figure 34. Americas Antiviral Drug Packaging Sales Market Share by Country in 2022
Figure 35. Americas Antiviral Drug Packaging Revenue Market Share by Country in 2022
Figure 36. Americas Antiviral Drug Packaging Sales Market Share by Material (2018-2023)
Figure 37. Americas Antiviral Drug Packaging Sales Market Share by Application (2018-2023)
Figure 38. United States Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Antiviral Drug Packaging Sales Market Share by Region in 2022
Figure 43. APAC Antiviral Drug Packaging Revenue Market Share by Regions in 2022
Figure 44. APAC Antiviral Drug Packaging Sales Market Share by Material (2018-2023)
Figure 45. APAC Antiviral Drug Packaging Sales Market Share by Application (2018-2023)
Figure 46. China Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Antiviral Drug Packaging Sales Market Share by Country in 2022
Figure 54. Europe Antiviral Drug Packaging Revenue Market Share by Country in 2022
Figure 55. Europe Antiviral Drug Packaging Sales Market Share by Material (2018-2023)
Figure 56. Europe Antiviral Drug Packaging Sales Market Share by Application (2018-2023)
Figure 57. Germany Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Antiviral Drug Packaging Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Antiviral Drug Packaging Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Antiviral Drug Packaging Sales Market Share by Material (2018-2023)
Figure 65. Middle East & Africa Antiviral Drug Packaging Sales Market Share by Application (2018-2023)
Figure 66. Egypt Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Antiviral Drug Packaging Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Antiviral Drug Packaging in 2022
Figure 72. Manufacturing Process Analysis of Antiviral Drug Packaging
Figure 73. Industry Chain Structure of Antiviral Drug Packaging
Figure 74. Channels of Distribution
Figure 75. Global Antiviral Drug Packaging Sales Market Forecast by Region (2024-2029)
Figure 76. Global Antiviral Drug Packaging Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Antiviral Drug Packaging Sales Market Share Forecast by Material (2024-2029)
Figure 78. Global Antiviral Drug Packaging Revenue Market Share Forecast by Material (2024-2029)
Figure 79. Global Antiviral Drug Packaging Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Antiviral Drug Packaging Revenue Market Share Forecast by Application (2024-2029)


More Publications